![](/img/cover-not-exists.png)
Phase II study of pegylated liposomal doxorubicin, low-dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple myeloma
Baz, Rachid C., Shain, Kenneth H., Hussein, Mohamad A., Lee, Ji-Hyun, Sullivan, Daniel M., Oliver, Elizabeth Finley, Nardelli, Lisa A., Nodzon, Lisa A., Zhao, Xiuhua, Ochoa-Bayona, Jose Leonel, NishihVolume:
89
Language:
english
Journal:
American Journal of Hematology
DOI:
10.1002/ajh.23587
Date:
January, 2014
File:
PDF, 501 KB
english, 2014